...
机译:单一中心经验中肌培养型肿瘤患者患者的血栓血栓形成的结果
Tisch Cancer InstituteIcahn School of Medicine at Mount SinaiNew York New York;
Division of Liver DiseasesIcahn School of Medicine at Mount SinaiNew York New York;
Department of Population Health Science and Policy/Tisch Cancer InstituteIcahn School of Medicine;
Tisch Cancer InstituteIcahn School of Medicine at Mount SinaiNew York New York;
Tisch Cancer InstituteIcahn School of Medicine at Mount SinaiNew York New York;
Tisch Cancer InstituteIcahn School of Medicine at Mount SinaiNew York New York;
Division of Liver DiseasesIcahn School of Medicine at Mount SinaiNew York New York;
Tisch Cancer InstituteIcahn School of Medicine at Mount SinaiNew York New York;
direct oral anti‐coagulant; myeloproliferative; splanchnic vein; thrombosis;
机译:单一中心经验中肌培养型肿瘤患者患者的血栓血栓形成的结果
机译:单一中心经验中肉芽糖尿病患者腹部血栓形成的结果
机译:内脏静脉血栓形成的临床表现,危险因素,治疗和结局:单中心经验
机译:临床特征在透明或混合变种类型的Castleman疾病中的七名患者结束。单一中心经验
机译:两种临床尺度的性能比较评估后血栓形成后综合征:对深静脉血栓形成的药物机械导管导向溶栓的多中心随机试验的二次分析
机译:JAK2V617F骨髓增生性肿瘤和内脏静脉血栓形成患者缺乏JAK2V617F突变的内皮细胞集落形成细胞
机译:JAK2V617F在患有JAK2V617F肌酚肌瘤肿瘤和血管静脉血栓形成患者中突变的内皮菌落形成细胞